A 150.8% profit surge in one quarter
Aayush Wellness reported Q1 FY27 revenue of ₹33.11 crore, up 46.3% year-on-year. Profit after tax hit ₹1.42 crore, a 150.8% sequential jump, as its herbal and nutraceutical pivot gained speed.
Aayush Wellness reported Q1 FY27 revenue of ₹33.11 crore, up 46.3% year-on-year. Profit after tax hit ₹1.42 crore, a 150.8% sequential jump, as its herbal and nutraceutical pivot gained speed.
Incorporated in 1984, Aayush began as an agricultural commodity exporter, trading basmati and non-basmati rice. It listed on BSE in 1987, later changed names, and rebranded as Aayush Wellness Limited in June 2024 after pivoting to preventive healthcare.
Its flagship Aayush Herbal Paan Masala replaces areca nut, tobacco, slaked lime and magnesium carbonate with Ayurvedic botanicals like Kaunch Beej, Ashwagandha, Mulethi and Amla. It targets India's pan masala market, valued at ₹42,309–48,460 crore.
Beyond herbal pan masala, the company sells Lung Care Tablets, Dreamy Sleep Gummies, Dia Shield Tablets, Liver Detox Tablets and Beauty Vitamin Gummies. A ₹10 sachet variant aims at price-sensitive consumers and general trade networks.
Consolidated revenue jumped from ₹0.60 crore in FY24 to ₹73.35 crore in FY25 and ₹155.45 crore in FY26, with trailing twelve-month sales at ₹166 crore. The pivot transformed a tiny commodity business into a fast-growing wellness company.
Q1 FY27 revenue reached ₹33.11 crore, up from ₹22.63 crore a year earlier. Gross profit rose 51.57% to ₹0.77 crore. The company has integrated its portfolio with Blinkit, converting health purchases into quick, impulse buys.
Q1 FY27 net profit after tax was ₹1.42 crore, up 22.6% year-on-year from Q1 FY26 and 150.8% sequentially from Q4 FY26. Revenue of ₹33.11 crore grew 46.3% over the same quarter last year.
Scale came with thinner operating margins: 58.0% in FY24, 4.6% in FY25 and 1.2% in FY26. Trailing twelve-month operating margin was 1.3%, meaning the business is far less profitable per rupee of sales than it first appears.
Since late 2023, promoter holding has been 0.00%; largest disclosed shareholders include Skybridge Incap Advisory LLP at 16.89% and V Cats Consultancy LLP at 13.42%. It must also manage food regulator FSSAI packaging rules, pan masala GST, and scrutiny of herbal tobacco-cessation claims.
Aayush Wellness has used a fast pivot to preventive healthcare and quick-commerce distribution to post rapid top-line growth. Its next test is sustaining profit margins while meeting packaging and advertising rules. Read the full article to dig deeper.
Read the full analysis →